findmyKOL

Devi Nair, MD

Enriched profile

Director, Cardiac Electrophysiology Division, St. Bernard's Heart & Vascular Center · St. Bernard's Heart & Vascular Center

ORCIDNPI
Region🇺🇸 Jonesboro, AR · South Central · United StatesSpecialtyClinical Cardiac ElectrophysiologyFocusAtrial Fibrillation
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Devi Nair is Director, Cardiac Electrophysiology Division, St. Bernard's Heart & Vascular Center at St. Bernard's Heart & Vascular Center. OpenAlex indexes 202 publications with 2,212 citations (h-index 25); ClinicalTrials.gov lists 12 registered studies with this person as an investigator.

Data verified 25 Aug 2026

Overview

Updated 1 Sept 2026

Devi G. Nair, MD, is Director, Cardiac Electrophysiology Division, St. Bernard's Heart & Vascular Center. The public record shows 202 publications with 2,212 citations (h-index 25), centered on Atrial Fibrillation. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 31 companies.

  • Most recent indexed publication: 2026 · medRxiv
  • Top research focus: Atrial Fibrillation
  • 12 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 31 companies

Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Atrial Fibrillation9 trialsArrhythmias, Cardiac2 trialsStroke2 trialsST Elevation Myocardial Infarction2 trialsEmbolism2 trialsBradycardia1 trialTachycardia, Ventricular1 trialVentricular Fibrillation1 trialTachycardia1 trial

Research focus

OpenAlex concept fingerprint
Atrial Fibrillation

Drugs & molecules

across trials, industry payments and publications
Xareltogeneric · RivaroxabanClinical trialsIndustry payments17PublicationsEliquisgeneric · ApixabanClinical trialsIndustry payments6PublicationsNirmatrelvirClinical trialsIndustry payments2Publications

Works with

trial sponsors and companies reporting payments
Boston Scientific CorporationClinical trials3Industry payments679Biosense Webster, Inc.Clinical trials1Industry payments162Abbott LaboratoriesClinical trialsIndustry payments895

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
202publications

Distinct works indexed by OpenAlex, matched via ORCID; 22 in PubMed.

2,212citations

Total citations across indexed works.

25h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
12clinical trials

Investigator role on registered studies.

View trials
31companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 1 Sept 2026

Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 1 Sept 2026

31 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    66.1%
    Beta blocker41.2%
    Sotalol72%Metoprolol Succinate15%Carvedilol11%Metoprolol Tartrate2%
    Part D400 patients
    Antiarrhythmic14.5%
    Amiodarone Hcl52%Flecainide Acetate27%Dofetilide12%Mexiletine Hcl7%Multaq2%
    Part D<11 patients
  • Blood & clotting

    27.6%
    Factor Xa inhibitor25.9%
    Eliquis87%Xarelto13%
    Part D277 patients
    P2Y12 inhibitor1.3%
    Clopidogrel100%
    Part D27 patients
  • Respiratory

    4.2%
    RNA Synthetase Inhibitor Antibacterial4.2%
    Mupirocin100%
    Part D269 patients
3 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)11.5% facility · 88.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 1 Sept 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 1 Sept 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/drdevignair

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • X / Twitter

    x.com/drdevignair

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/stbmd/posts/dr-devi-nair-st-bernards-heart-care-director-of-cardiac-electrophysiology-discus/4818490244834426

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • Other

    hmpgloballearningnetwork.com/site/eplab/podcasts/innovation-and-passion-electrophysiology-interview-devi-nair-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmpgloballearningnetwork.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 1 Sept 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Chair/Vice-Chair

    Heart Rhythm Society Membership Subcommittee

    2022
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →stbernards.info
  • Director

    Cardiac Electrophysiology Division, St. Bernard's Heart & Vascular Center, Jonesboro, AR

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scai.org
  • President/CEO

    Arrhythmia Research Group

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →innovationsincrm.com
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.